Skip to main content
. 2021 Sep 10;74(3):195–208. doi: 10.1159/000519381

Table 1.

Demographic and clinical profiles of the study participants

Characteristic n (valid %)
Sex
 Woman 133 (42.4)
 Man 181 (57.6)
Age, years
 <65 65 (20.1)
 65–74 82 (26.1)
 75–84 110 (35.0)
 ≥85 57 (18.2)
 Mean ± SD, range 72.7±12.9
Disease duration (days)
 <10 99 (31.5)
 10–29 61 (19.4)
 30–59 55 (17.8)
 60–180 96 (30.6)
 Undetectablea 2 (0.6)
 Mean ± SD, range 45.7±47.8
Etiology
 Infarction 204 (65.0)
 Hemorrhage 67 (21.3)
 Subarachnoid hemorrhage 12 (3.8)
 Trauma 11 (3.5)
 Others 20 (5.7)
Brain lesion
 Left hemisphere 132 (42.0)
 Right hemisphere 101 (32.2)
 Bilateral hemisphere 13 (4.1)
 Cerebellum/brainstem 36 (11.5)
 Othersb 26 (8.3)
 Missingc 6 (1.9)
Brain injury severity
 mRS 0 7 (2.2)
 mRS 1 34 (10.8)
 mRS 2 71 (22.6)
 mRS 3 54 (17.2)
 mRS 4 110 (35.0)
 mRS 5 38 (12.1)
 mRS 6 0 (0)
 Mean ± SD 3.1±1.3

mRS, Modified Rankin Scale; SD, standard deviation.

a

Undetectable onset day of chronic subdural hematoma patients who had not undergone surgery.

b

Atypical lesion (e.g., hemispheric and cerebellum/brainstem simultaneous lesions caused by multiple cerebral infarctions or lesions without focal sites caused by hydrocephalus, subarachnoid hemorrhage, subdural hematoma, or epilepsy.

c

Containing data inadequacy.